PRINciples of optimal antithrombotiC therapy and coagulation managEment during elective fenestrated and branched EndovaScular aortic repairS (PRINCE2SS): an international expert-based Delphi consensus study.
Mario D’Oria,Luca Bertoglio,Angelo Antonio Bignamini,Kevin Mani,Tilo Kölbel,Gustavo Oderich,Roberto Chiesa,Sandro Lepidi,PRINCE2SS collaborative study group,Said Abisi,Donald Adam,Michele Antonello,Martin Austermann,Adam W. Beck,Xavier Berard,Theodosios Bisdas,Dittmar Böckler,Jacob Budtz-Lilly,Stephen W.K. Cheng,Martin Czerny,Randall DeMartino,Nuno Dias,Konstantinos P. Donas,Matthew J. Eagleton,Mark A. Farber,Aaron Thomas Fargion,Marcelo Ferreira,Thomas L. Forbes,Mauro Gargiulo,Warren J. Gasper,Tomasz Jakimowicz,Stéphan Haulon,Joseph A. Hockley,Andrew Holden,Peter Holt,Andrea Kahlberg,Manar Khashram,Drosos Kotelis,Göran Lundberg,Thomas S. Maldonado,Nicola Mangialardi,Tara M. Mastracci,Blandine Maurel,Ross Milner,Bijan Modarai,Giuseppe Pannuccio,Gianbattista Parlani,Giovanni Pratesi,Raffaele Pulli,Raffi A. Qasabian,Michel M.P. J. Reijnen,Timothy Resh,Vincente Riambau,Nicla Settembre,Andres Schanzer,Andrej Schmidt,Darren Schneider,Geert Willem H. Schurink,Roberto Silingardi,Jonathan Sobocinski,Raphael Soler,Matthew P. Sweet,Glenn Wei Leong Tan,Emanuel R. Tenorio,Ignace F.J. Tielliu,Carlos H. Timaran,Yamume Tshomba,Nikolaos Tsilimparis,Wouter Van den Eynde,Thodur Vasudevan,Gian Franco Veraldi,Hence JM. Verhagen,Eric Verhoeven,Fabio Verzini,Anders Wanhainen,Alexander Zimmermann
DOI: https://doi.org/10.1016/j.ejvs.2022.03.002
IF: 6.427
2022-03-01
European Journal of Vascular and Endovascular Surgery
Abstract:ObjectiveManagement of antithrombotic therapy in patients undergoing elective fenestrated-branched endovascular aortic repair (F-BEVAR) is not standardized, nor is there any recommendations from current guidelines. By designing an international expert-based Delphi consensus, the study aimed to create recommendations on preoperative, intraoperative, and postoperative management of antithrombotic therapy in patients scheduled for elective F-BEVAR in high-volume centers.MethodsEight facilitators created appropriate statements regarding the study topic that were voted, using a 4-point Likert scale, by a selected panel of international experts using a three-round modified Delphi consensus process. Based on the experts' responses, only those statements reaching a Grade A (full agreement ≥75%) or B (overall agreement ≥80% and full disagreement <5%) were included in the final document. The round answers' consistency was graded using the Cohen's k, the intraclass correlation coefficient and, in case of double resubmission, the Fleiss k.ResultsSixty-seven experts were included in the final analysis and voted the initial 43 statements related to preoperative (n=15), intraoperative (n= 10), and postoperative (n= 18) management of antithrombotic drugs. At the end of the process, 6 statements (13%) were rejected, 20 statements (44%) received a grade B consensus strength, and 18 statements (40%) reached a grade A consensus. Most statements (27; 71%) exhibited very high or high consistency grades, and 11 (29%) a fair or poor grading. The intraoperative statements mostly concentrated on threshold of and monitoring for proper heparinization. The preoperative and postoperative statements mainly focused on indications for dual antiplatelet therapy and its management, considering the possible need for cerebrospinal fluid drainage.ConclusionsBased on the elevated strength and high consistency of this international expert-based Delphi consensus, most of the statements might guide current clinical management of antithrombotic therapy for elective F-BEVAR. Future studies are needed to clarify debated issues.
surgery,peripheral vascular disease